Catalysts for Praluent
14 tracked
Oct 9, 2025
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Mar 8, 2024
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Apr 1, 2021
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Apr 1, 2021
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Mar 10, 2020
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Apr 26, 2019
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Apr 26, 2019
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Nov 6, 2018
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Aug 22, 2018
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Jul 20, 2018
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Sep 20, 2017
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Jul 27, 2017
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Apr 24, 2017
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→
Jul 24, 2015
approval
PRALUENT (ALIROCUMAB) — FDA approval
alirocumab
→